| Dr Timothy M Gold, MD | |
|
900 E Broadway Avenue, Bismarck, ND 58501-4520 | |
| (701) 530-7000 | |
| Not Available |
| Full Name | Dr Timothy M Gold |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 900 E Broadway Avenue, Bismarck, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558348193 | NPI | - | NPPES |
| 170295500 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 36151 (Minnesota) | Secondary |
| 207L00000X | Anesthesiology | 4989 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Timothy M Gold, MD Po Box 997, Bismarck, ND 58502-0997 Ph: (701) 530-7000 | Dr Timothy M Gold, MD 900 E Broadway Avenue, Bismarck, ND 58501-4520 Ph: (701) 530-7000 |
News Archive
Current understanding of seizures in the weeks just after epilepsy surgery is that they are likely to be temporary, probably due to swelling or minor trauma suffered by the brain during the operation.
Cortex Pharmaceuticals, Inc. announced that it has received notification from the NYSE Amex LLC indicating that, due to the Company's non-compliance with certain continued listing standards as previously reported, the Exchange intends to delist the Company's common stock from the NYSE Amex effective as of the close of business on Friday, December 11, 2009.
The U.S. Chamber of Commerce today commended the approval of comprehensive medical liability reform legislation by the House Judiciary Committee. The legislation – H.R. 5, the Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act – was approved by the committee yesterday by a vote of 18 to 15 and now goes to the full House of Representatives for consideration.
Bristol-Myers Squibb Company and The University of Texas MD Anderson Cancer Center today announced a novel clinical research collaboration to evaluate multiple immunotherapies, including Opdivo (nivolumab), Yervoy (ipilimumab) and three early-stage clinical immuno-oncology assets from Bristol-Myers Squibb, as potential treatment options for acute and chronic leukemia as well as other hematologic malignancies.
› Verified 8 days ago
Calvin Motika, M.D Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 900 E Broadway Ave, Bismarck, ND 58501 Phone: 701-530-7000 | |
Dr. Samuel Aguhob, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 Fax: 701-323-5709 | |
George Kwitka, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 Fax: 701-323-5709 | |
Hugh S Carlson, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 202 E Greenfield Ln Ste 100, Bismarck, ND 58503 Phone: 701-223-7822 Fax: 701-223-7844 | |
Diosdado T Jaramillo, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 | |
Dr. Michael Jankoviak, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 310 N 10th St, Bismarck, ND 58501 Phone: 701-530-7500 Fax: 701-530-7484 | |
Nathan Aaron Bro, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 |